328 related articles for article (PubMed ID: 37374286)
1. Functional Disability and Brain MRI Volumetry Results among Multiple Sclerosis Patients during 5-Year Follow-Up.
Strautmane S; Balodis A; Teivane A; Grabovska D; Naudins E; Urbanovics D; Fisermans E; Mednieks J; Flintere-Flinte A; Priede Z; Millers A; Zolovs M
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374286
[No Abstract] [Full Text] [Related]
2. Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study.
Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Barkhof F; Schoonheim MM; Strijbis EM; Vrenken H; Gallo A; Bisecco A; Ciccarelli O; Yiannakas M; Rovira A; Sastre-Garriga J; Palace J; Matthews L; Gass A; Eisele P; Lukas C; Bellenberg B; Margoni M; Preziosa P; Filippi M;
J Neurol Neurosurg Psychiatry; 2023 Jan; 94(1):10-18. PubMed ID: 36171105
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of single-subject grey matter networks in early multiple sclerosis.
Fleischer V; Gonzalez-Escamilla G; Pareto D; Rovira A; Sastre-Garriga J; Sowa P; Høgestøl EA; Harbo HF; Bellenberg B; Lukas C; Ruggieri S; Gasperini C; Uher T; Vaneckova M; Bittner S; Othman AE; Collorone S; Toosy AT; Meuth SG; Zipp F; Barkhof F; Ciccarelli O; Groppa S
Brain; 2024 Jan; 147(1):135-146. PubMed ID: 37642541
[TBL] [Abstract][Full Text] [Related]
4. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
[TBL] [Abstract][Full Text] [Related]
5. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
6. Corpus callosum index correlates with brain volumetry and disability in multiple sclerosis patients.
Sugijono SE; Mulyadi R; Firdausia S; Prihartono J; Estiasari R
Neurosciences (Riyadh); 2020 Jul; 25(3):193-199. PubMed ID: 32683399
[TBL] [Abstract][Full Text] [Related]
7. Grey:white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression.
Moccia M; Quarantelli M; Lanzillo R; Cocozza S; Carotenuto A; Carotenuto B; Alfano B; Prinster A; Triassi M; Nardone A; Palladino R; Brunetti A; Brescia Morra V
Eur J Neurol; 2017 Jan; 24(1):195-204. PubMed ID: 27801535
[TBL] [Abstract][Full Text] [Related]
8. Modelling disease progression in relapsing-remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort.
Tilling K; Lawton M; Robertson N; Tremlett H; Zhu F; Harding K; Oger J; Ben-Shlomo Y
Health Technol Assess; 2016 Oct; 20(81):1-48. PubMed ID: 27817792
[TBL] [Abstract][Full Text] [Related]
9. Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis.
Magon S; Tsagkas C; Gaetano L; Patel R; Naegelin Y; Amann M; Parmar K; Papadopoulou A; Wuerfel J; Stippich C; Kappos L; Chakravarty MM; Sprenger T
J Neurol; 2020 May; 267(5):1536-1546. PubMed ID: 32040710
[TBL] [Abstract][Full Text] [Related]
10. Central nervous system atrophy predicts future dynamics of disability progression in a real-world multiple sclerosis cohort.
Tsagkas C; Naegelin Y; Amann M; Papadopoulou A; Barro C; Chakravarty MM; Gaetano L; Wuerfel J; Kappos L; Kuhle J; Granziera C; Sprenger T; Magon S; Parmar K
Eur J Neurol; 2021 Dec; 28(12):4153-4166. PubMed ID: 34487400
[TBL] [Abstract][Full Text] [Related]
11. Brain atrophy and lesion load predict long term disability in multiple sclerosis.
Popescu V; Agosta F; Hulst HE; Sluimer IC; Knol DL; Sormani MP; Enzinger C; Ropele S; Alonso J; Sastre-Garriga J; Rovira A; Montalban X; Bodini B; Ciccarelli O; Khaleeli Z; Chard DT; Matthews L; Palace J; Giorgio A; De Stefano N; Eisele P; Gass A; Polman CH; Uitdehaag BM; Messina MJ; Comi G; Filippi M; Barkhof F; Vrenken H;
J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1082-91. PubMed ID: 23524331
[TBL] [Abstract][Full Text] [Related]
12. Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression.
Preziosa P; Pagani E; Meani A; Moiola L; Rodegher M; Filippi M; Rocca MA
Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 35105685
[TBL] [Abstract][Full Text] [Related]
13. Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.
Hofstetter L; Naegelin Y; Filli L; Kuster P; Traud S; Smieskova R; Mueller-Lenke N; Kappos L; Gass A; Sprenger T; Penner IK; Nichols TE; Vrenken H; Barkhof F; Polman C; Radue EW; Borgwardt SJ; Bendfeldt K
Mult Scler; 2014 Feb; 20(2):202-13. PubMed ID: 23804554
[TBL] [Abstract][Full Text] [Related]
14. Predicting clinical progression and cognitive decline in patients with relapsing-remitting multiple sclerosis: a 6-year follow-up study.
Kania K; Pawlak MA; Forycka M; Wiłkość-Dębczyńska M; Michalak S; Łukaszewska A; Wyciszkiewicz A; Wypych A; Serafin Z; Marcinkowska J; Kozubski W; Kalinowska-Łyszczarz A
Neurol Neurochir Pol; 2024; 58(2):176-184. PubMed ID: 38324117
[TBL] [Abstract][Full Text] [Related]
15. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.
Rudick RA; Lee JC; Nakamura K; Fisher E
J Neurol Sci; 2009 Jul; 282(1-2):106-11. PubMed ID: 19100997
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis impairment scale and brain MRI in secondary progressive multiple sclerosis.
Theodorsdottir A; Larsen PV; Nielsen HH; Illes Z; Ravnborg MH
Acta Neurol Scand; 2022 Mar; 145(3):332-347. PubMed ID: 34799851
[TBL] [Abstract][Full Text] [Related]
17. MRI-Based Brain Volumetry at a Single Time Point Complements Clinical Evaluation of Patients With Multiple Sclerosis in an Outpatient Setting.
Raji A; Ostwaldt AC; Opfer R; Suppa P; Spies L; Winkler G
Front Neurol; 2018; 9():545. PubMed ID: 30140245
[No Abstract] [Full Text] [Related]
18. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
Galego O; Gouveia A; Batista S; Moura C; Machado E
Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
[TBL] [Abstract][Full Text] [Related]
19. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.
Calabrese M; Rocca MA; Atzori M; Mattisi I; Favaretto A; Perini P; Gallo P; Filippi M
Ann Neurol; 2010 Mar; 67(3):376-83. PubMed ID: 20373349
[TBL] [Abstract][Full Text] [Related]
20. Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study.
Hidalgo de la Cruz M; Valsasina P; Meani A; Gallo A; Gobbi C; Bisecco A; Tedeschi G; Zecca C; Rocca MA; Filippi M
Mult Scler; 2022 Mar; 28(3):406-417. PubMed ID: 34124963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
